Mevalonate Kinase Deficiency
📧 Sign up to get email alerts when something new happens for Mevalonate Kinase Deficiency.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Ilaris NIS in Korea
Novartis' canakinumab (Ilaris) is the subject of a Korea-based non-interventional study that is currently recruiting. The study covers hered…
-
CLINICAL_TRIALS research · 2024-07-12Clinical Trial Update: Geranylgeraniol Supplementation in Patients With Mevalonate Kinase Deficiency [NA]
A clinical trial update indicates that a study investigating geranylgeraniol supplementation in patients with mevalonate kinase deficiency i…
-
CLINICAL_TRIALS withdrawal · 2018-06-18Clinical Trial Update: B7 Coreceptor Molecules in Hyper IgD Syndrome Form of Mevalonate Kinase Deficiency
The trial NCT01568736 investigating B7 coreceptor molecules in Hyper IgD Syndrome form of Mevalonate Kinase Deficiency has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-08-19Clinical Trial Update: Canakinumab in Patients With Active Hyper-IgD Syndrome [Phase 2]
Phase 2 trial of canakinumab for active Hyper-IgD syndrome due to mevalonate kinase deficiency has completed, with results posted in 2015.